Clinical Trial Update: Dabrafenib + Trametinib + PDR001 In Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial investigating dabrafenib + trametinib in combination with PDR001 for metastatic colorectal cancer is in early evaluation with an unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Dabrafenib (Dabrafenib)
• PDR001
• Trametinib (trametinib)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Metastatic Colorectal Cancer | Phase 2 | Status: UNKNOWN